Abstract 4141543: Exercise-induced cardiomyopathy in the absence of coronary artery disease: Clinical characteristics and outcomes.
Background: Patients with normal resting left ventricular ejection fraction (LVEF) without either coronary artery disease (CAD) or a hypertensive response can paradoxically develop reduced LVEF during exercise stress echocardiography (ESE). The clinical phenotype and outcomes of these patients is unknown. Hypothesis: Patients who paradoxically develop reduced LVEF during exercise may represent a sub-phenotype of heart failure with preserved LVEF (HFpEF). Aims: To describe the baseline characteristics and clinical outcomes of this unique patient population. Methods: Among all ESE performed between January 2003 and December 2022, patients without a hypertensive response to exercise and without CAD by angiogram within 90 days of ESE, who had a resting LVEF ≥50% with a ≥5% LVEF decrease during ESE were identified. All-cause mortality, HF hospitalization, and atrial fibrillation (AF) outcomes were assessed. Kaplan-Meier and Cox regression methods were used to analyze time-to-event outcomes. Results: Among 213,643 stress echocardiograms performed, 134 patients met eligibility criteria (Table 1). The mean age of the population was 66±10 years, 76% were women, and 16% had AF at baseline. Mean LVEF was 58±4% at rest and 43±4% at peak stress. Stress electrocardiogram met criteria for ischemia in 14%. The 10-year all-cause mortality risk was 12.9% (95% CI 5.5-20.3) with 10 (37%) of 27 deaths due to cancer (Figure 1, Panel A). The 10-year estimated risk of HF hospitalization was 17.6% (95% CI 9.0-26.2) (Figure 1, Panel B). Among 112 patients without AF at baseline, the 10-year risk of developing AF was 23.4% (95% CI 13.4-33.4). Conclusions: Patients with exercise-induced reduced LVEF in the absence of obstructive CAD have a high incidence of HF hospitalizations and AF. Given the preponderance of women, risk for AF, HF hospitalizations, and cancer-related deaths, the possibility that this condition is an early sub-phenotype of HFpEF should be investigated.
Authors
- Rachad Ghazal (ORCID: https://orcid.org/0009-0001-4790-5283)
- Robert B. McCully (ORCID: https://orcid.org/0000-0003-2768-4652)
- Naveen L. Pereira (ORCID: https://orcid.org/0000-0003-3813-3469)
- Roberta Montisci (ORCID: https://orcid.org/0000-0002-7218-6751)
- Luca Fazzini (ORCID: https://orcid.org/0000-0003-2407-7435)
- Scott Hubers (ORCID: https://orcid.org/0000-0001-8129-2452)
- Patricia A. Pellikka (ORCID: https://orcid.org/0000-0001-6800-3521)
- Marta Figueiral (ORCID: https://orcid.org/0000-0003-3308-774X)
- Min Wang (ORCID: https://orcid.org/0000-0001-6759-9132)
- Akanksha Mohananey
- Jenny Jia Ling Cao (ORCID: https://orcid.org/0000-0002-7167-004X)
- Matteo Castrichini (ORCID: https://orcid.org/0000-0002-2405-3364)
- Rajiv Gulati
- Christopher Scott (ORCID: https://orcid.org/0000-0001-5923-8994)
- Li Wang (ORCID: https://orcid.org/0000-0002-0496-9500)
Institutions
- Mayo Clinic (US)
- University of Cagliari (IT)
Publication Details
- Journal
- Circulation
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1161/circ.150.suppl_1.4141543
- Primary Topic
- Cardiovascular and exercise physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00